Author

M.V.G. Frias

Observed names: M. V. G. Frias, M.V.G. Frias IV, Melchor V G Frias, Melchor V. Frias, Melchor V. G. Frias, Melchor Victor Frias

Institutions: Clinical Innovations (United States), De La Salle University – Dasmariñas

Observed institutions: Clinical Innovations (United States), De La Salle Medical and Health Sciences Institute, University of the Philippines Manila, De La Salle University – Dasmariñas

ORCID: 0000-0003-3716-9419

Observed ORCID: 0000-0003-3716-9419

OpenAlex ID: A5108958974

Bedaquiline for multidrug-resistant TB in paediatric patients

2021 · R. Moodliar, V. Aksenova, et al. · The International Journal of Tuberculosis and Lung Disease · 27

Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study

2024 · Brandon J. Essink, Craig Shapiro, et al. · Human Vaccines & Immunotherapeutics · 7

Feasibility and acceptability of asynchronous VOT among patients with MDR-TB

2022 · D. J. O. Casalme, D. B. Marcelo, et al. · The International Journal of Tuberculosis and Lung Disease · 6

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis

2025 · Megan Palmer, Yuanxi Zou, et al. · British Journal of Clinical Pharmacology · 5

Pharmaceutical cost dynamics for the treatment of rifampicin-resistant tuberculosis in children and adolescents in South Africa, India, and the Philippines

2024 · Thomas Wilkinson, Anthony J. Garcia-Prats, et al. · PLoS ONE · 4

Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries

2025 · L. Viljoen, H.R. Draper, et al. · IJTLD OPEN · 2

Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries

2025 · N. Suryavanshi, H.R. Draper, et al. · IJTLD OPEN · 1

Pharmacokinetics of Clofazimine Tablet Formulation in Children with Rifampicin-Resistant Tuberculosis in CATALYST, a Multi-Site International Trial

2026 · Yuanxi Zou, Megan Palmer, et al. · Journal of the Pediatric Infectious Diseases Society

Bedaquiline for Multi Drug-Resistant, Including Extensively or Pre-Extensively Drug-Resistant, Pulmonary Mycobacterium Tuberculosis in Children

2020 · R. Moodliar, V. Aksenova, et al.

Works count: 9

Citation count: 51

H-index: 4

I10-index: 1